Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engert

Showing results (131-140 of 173) with videos related to

Pageof 18
Sort By:
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]J O Staak, M Dietlein, A Engert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 29, 2016
New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study GroupJ Kriz, C Baues, R Engenhart-Cabillic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2013
Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphomaR Herbrecht, P Cernohous, A Engert, et al.
Annals of Hematology|May 10, 2000
Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomyH Schäfer, K Hübel, H Bohlen, et al.
Journal of Biological Response Modifiers|August 1, 1987
Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2J E Kolitz, K Welte, G Y Wong, et al.
Investigational New Drugs|September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinomaP B Chapman, J E Kolitz, T B Hakes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 7, 2016
Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG)J Kriz, C Baues, R Engenhart-Cabillic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2010
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study GroupK Behringer, L Wildt, H Mueller, et al.
International Journal of Colorectal Disease|May 17, 2002
The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in miceK Pfister, B M Wittig, B Jüngling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II studyA Josting, M Sieniawski, J-P Glossmann, et al.
Pageof 18

Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]J O Staak, M Dietlein, A Engert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 29, 2016
New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study GroupJ Kriz, C Baues, R Engenhart-Cabillic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2013
Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphomaR Herbrecht, P Cernohous, A Engert, et al.
Annals of Hematology|May 10, 2000
Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomyH Schäfer, K Hübel, H Bohlen, et al.
Journal of Biological Response Modifiers|August 1, 1987
Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2J E Kolitz, K Welte, G Y Wong, et al.
Investigational New Drugs|September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinomaP B Chapman, J E Kolitz, T B Hakes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 7, 2016
Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG)J Kriz, C Baues, R Engenhart-Cabillic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2010
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study GroupK Behringer, L Wildt, H Mueller, et al.
International Journal of Colorectal Disease|May 17, 2002
The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in miceK Pfister, B M Wittig, B Jüngling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II studyA Josting, M Sieniawski, J-P Glossmann, et al.
Pageof 18